Australia appeals after Italy, EU block AstraZeneca vaccines

Australia appeals after Italy, EU block AstraZeneca vaccines

access_time2021-03-05 14:39:18

Australia said it had asked for a review after its shipment of a quarter of a million AstraZeneca vaccines was blocked from leaving the European Union in the bloc’s first use of an export control system designed to ensure big pharma companies would respect their contracts.

Italy’s order blocking the dispatch of 250,000 doses was accepted by the European Commission, which has fiercely criticised the Anglo-Swedish company this year for supplying just a fraction of the vaccine doses it had promised.

The move, affecting only a small number of vaccines, underscores a growing frustration within the 27-nation bloc about the slow rollout of its vaccine drive and the shortfall of promised vaccine deliveries, especially by AstraZeneca.

“Australia has raised the issue with the European Commission through multiple channels, and in particular we have asked the European Commission to review this decision,” Australian Health Minister Greg Hunt told reporters in Melbourne on Friday.

Hunt said Australia had already received 300,000 doses of the AstraZeneca shot, which would last until it was able to produce more of the vaccine locally.

The Financial Times first reported that Italy had pushed for the ban on Thursday. The government of Mario Draghi, which came into power last month, has been taking a tougher line in dealing with vaccine shortages.

While seeking the European Commission’s intervention, Australia’s Prime Minister Scott Morrison said he could understand the reasons for Italy’s objection.

“In Italy people are dying at the rate of 300 a day. And so I can certainly understand the high level of anxiety that would exist in Italy and in many countries across Europe,” Morrison told reporters in Sydney.

Faced with shortages of doses during the early stages of the vaccine campaign that started in late December, the EU established an export control system for COVID-19 vaccines.

Under the commission’s “transparency and authorisation mechanism” EU member states vet planned exports of authorised COVID-19 vaccines that leave the bloc.

The EU has been specifically angry with AstraZeneca because it is delivering far fewer doses to the region than it had promised. Of the initial 80 million doses the EU ordered for the first quarter, the company will be struggling to deliver just half that quantity.


Similar News